LGNDCommon stockNASDAQ
LGND Common stock
This is the ticker-level security page. The issuer is Ligand Pharmaceuticals, Inc..
Security details
Issuer financial context
These figures belong to the issuer company, not to this security itself.
Revenue TTM
$251.2M
Net income TTM
$48.6M
Total assets
$1.5B
Total debt
Not available
Total equity
$950.2M
Profit margin
19.3%
ROE
5.1%
ROA
3.3%
Latest issuer financial snapshot: 2024-12-31